Mood and Anxiety Disorders: Bipolar Disorder.

Area of Science:

• Psychiatry
• General Medicine
• Pharmacology

Background:

• Bipolar I disorder affects 0.4%-1% globally, causing significant economic burden due to functional impairment.
• Primary care physicians (PCPs) frequently manage bipolar disorder (BD) due to specialist access challenges.
• Up to 4% of patients in primary care settings may have undiagnosed BD.

Purpose of the Study:

• To outline the challenges and current management strategies for Bipolar I disorder in primary care.
• To emphasize the diagnostic complexity and the role of PCPs in BD management.
• To review established and emerging treatment options for BD.

Main Methods:

• Comprehensive clinical assessment is required for BD diagnosis, as screening tools are insufficient.
• Review of current pharmacological treatments, including mood stabilizers, anticonvulsants, and antipsychotics.
• Discussion of psychotherapy as an adjunct therapy and the potential role of mental health clinicians.

Main Results:

• Lithium is the gold-standard for BD management and maintenance therapy in adults.
• Certain anticonvulsants and atypical antipsychotics are also effective for maintenance.
• Psychotherapy, including cognitive behavioral therapy and psychoeducation, serves as a useful adjunct therapy.

Conclusions:

• PCPs play a crucial role in managing Bipolar I disorder, necessitating comprehensive assessment and treatment strategies.
• Established treatments like lithium, alongside other medications and psychotherapy, are key to effective BD management.
• Collaboration between PCPs and mental health specialists can improve patient outcomes.